English and Spanish
(800) CDC-INFO
(800) 232-4636
TTY: (888) 232-6348
FAX: (770) 488-4760

International Travel
Phone: 1-887-394-8747
email: cdcinfo@cdc.gov

Haemophilus influenzae Serotype b (Hib) Disease

 MMWR Articles

	CDC. Progress Toward Introduction of Haemophilus influenzae type b Vaccine in Low-Income Countries -- Worldwide, 2004-2007. MMWR Vol 57; No 6;148 02/15/2008.
	CDC. Interim Recommendations for the Use of Haemophilus influenzae Type b (Hib) Conjugate Vaccines Related to the Recall of Certain Lots of Hib-Containing Vaccines (PedvaxHIB® and Comvax®). MMWR Vol. 56; No 50;1318 12/21/2007
	CDC. Progress Toward Elimination of Haemophilus influenzae Type b Invasive Disease among infants and children, United States, 1998-2000. MMWR Vol 51, No 11;234 03/22/2002
	CDC. Combination Vaccines for Childhood Immunization, MMWR Vol 48, No RR05;1 05/14/1999
	CDC. Progress Toward Eliminating Haemophilus influenzae Type b Disease MMWR Vol 47, No 46;993 11/27/1998
	CDC. Haemophilus influenzae Invasive Disease Among Children Aged less than 5 years MMWR Vol 47, No 35;737 09/11/1998
	CDC. Progress Toward Elimination of Haemophilus influenzae Type b MMWR Vol 45, No 42;901 10/25/1996
	CDC. Progress Toward Elimination of Hib Disease Among Infants Children MMWR Vol 44, No 29;545 07/28/1995
	CDC. Recommendations for Use of Haemophilus b Conjugate Vaccines MMWR Vol 42, No RR13;001 09/17/1993
	ACIP Recommendations for Use of Haemophilus b Conjugate Vaccines and a Combined Diptheria, Tetanus, Pertussis, and Haemophilus b Vaccine MMWR Vol. 42 / RR-13
	Control and Prevention of Meningococcal Disease and Control and Prevention of Serogroup C Meningococcal Disease: Evaluation and Management of Suspected Outbreaks MMWR Recommendations and Reports February 14, 1997 / Vol.46 / No. RR-5

 Links

	ACIP recommendations
	Integrated Disease Surveillance and Response (IDSR)
	NIP's Manual for the surveillance for vaccine preventable diseases
	Laboratory Methods for the Diagnosis of Meningitis - Manual 1.4 MB

 References

CDC. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Haemophilus influenzae, 2006. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/hib06.pdf 93 KB

Rosenstein N, Perkins B. Update of Haemophilus influenzae serotype B and meningococcal vaccines. Ped Clin North Amer 2000; 47: 337-352.

Bisgard KM, Kao A, Leake JA, Strebel P, Perkins BA, Wharton M. Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerging Infectious Diseases 1998; 4(2): 229-237.

Galil K, Singleton R, Levine OS, et al. Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. Journal of Infectious Diseases 1999; 179: 101-106.

Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, Wenger JD. Decline of childhood Haemophilus influenzae type b disease in the Hib vaccine era. Journal of the American Medical Association 1993; 269: 221-226.

LaClaire LL, Tondella MLC, Beall DS, Nobel CA, Raghunatnan PL, Rosenstein NE, Popovic T, and the ABCs Team Members. Identification of Haemophilus influenzae serotypes by standard slide agglutination serotyping and PCR-based capsule typing. J Clin Microbiol 2003; 41(1): 393-396.